comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 14:16:07 - browse：95

ANDREW YATES/AFP via Getty Images

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program.

Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments. He wrote that AstraZeneca had not proved that Medicare’s new drug price negotiation program jeopardizes its constitutional property rights, and that the company didn’t have standing to challenge the guidance Medicare issued to implement the program.

The case is the first of a slew of cases filed by the pharmaceutical industry and its allies to be decided at the district court level. The Delaware ruling is a blow, as several of the other cases made similar arguments about how the program violates drugmakers’ constitutional property rights.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Congress may force more Covid

WSS

White House launches permanent pandemic office

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Weight loss drugs aren’t covered by Obamacare. That may change

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

HIPAA doesn't protect reproductive records from prosecutors

Researchers tackle phage therapy hurdles for wider adoption

focus

comprehensive

leisure time

The high cost of giving birth even with insurance

AbbVie dramatically boosts its spending on lobbying

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medicare Advantage enrollment hits roughly 33.4 million

The high cost of giving birth even with insurance

Our daughter's deadly disease: trisomy 18. We wanted to protect her

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Caitlin Bernard's story shows physicians can't shy from advocacy

Heart attack and stroke risk calculators need revising

Russian special forces kill a gunman who broke into a private house near Moscow

knowledge

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Researchers tackle phage therapy hurdles for wider adoption

Ukraine seeks to reclaim its role as a hub for clinical trials

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Russian special forces kill a gunman who broke into a private house near Moscow

Death toll from an explosion and collapse of a Paris building in June climbs to 3

explore

Wikipedia

knowledge

focus